Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
IL0010941198
Pharmaceuticals
| Market Cap | 1.24B 0 412M 357M 333M 305M 574M 39.23B 584M 3.91B 1.53B 19.66B 1.55B 1.51B 65B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.24B 0 412M 357M 333M 305M 574M 39.23B 584M 3.91B 1.53B 19.66B 1.55B 1.51B 65B | EV / Sales 2026 * |
2.06x | EV / Sales 2027 * | 1.89x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | -0.53% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 57 | 30/06/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 55 | 30/12/2017 |
Eran Nir
COO | Chief Operating Officer | 53 | 31/10/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 12/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 06/03/2013 |
| Chairman | 55 | 11/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -1.04% | - | - | 412M | |
| +1.45% | +4.71% | +45.62% | +0.25% | 78.32B | |
| +0.84% | +5.66% | -0.15% | +27.88% | 51.1B | |
| +0.85% | +1.67% | +20.63% | +176.54% | 49.18B | |
| +1.72% | +9.27% | -48.46% | -48.80% | 44.71B | |
| -0.01% | +2.61% | +61.79% | -23.03% | 30.72B | |
| +1.41% | +3.05% | +54.11% | +86.29% | 24.44B | |
| +1.58% | +8.36% | +134.59% | -40.42% | 23.62B | |
| +2.58% | +12.23% | +6.63% | +202.17% | 21.05B | |
| -0.20% | +3.67% | +65.57% | +115.44% | 16.61B | |
| Average | +0.93% | +3.74% | +37.82% | +55.15% | 37.75B | |
| Weighted average by Cap. | +1.14% | +3.83% | +29.56% | +42.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 600M 0 200M 173M 162M 148M 279M 19.06B 284M 1.9B 745M 9.55B 752M 735M 31.58B | 655M 0 218M 189M 176M 162M 304M 20.78B 309M 2.07B 812M 10.42B 820M 802M 34.43B |
| Net income | 73.89M 0 24.65M 21.32M 19.91M 18.27M 34.35M 2.35B 34.9M 234M 91.69M 1.18B 92.56M 90.53M 3.89B | 105M 0 35.17M 30.42M 28.41M 26.06M 49.02M 3.35B 49.79M 333M 131M 1.68B 132M 129M 5.55B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
